+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Artificial Saliva Market by Product Type, Formulation, End User, Distribution Channel, Indication, Packaging - Global Forecast to 2030- Product Image
Artificial Saliva Market by Product Type, Formulation, End User, Distribution Channel, Indication, Packaging - Global Forecast to 2030- Product Image
Sale

Artificial Saliva Market by Product Type, Formulation, End User, Distribution Channel, Indication, Packaging - Global Forecast to 2030

  • PDF Icon

    Report

  • 180 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5888518
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Artificial Saliva Market grew from USD 980.52 million in 2024 to USD 1.04 billion in 2025. It is expected to continue growing at a CAGR of 6.37%, reaching USD 1.42 billion by 2030.

Charting the Emerging Horizon of Artificial Saliva

The artificial saliva sector is entering a transformative era marked by an unprecedented convergence of clinical need, technological innovation, and shifting patient expectations. Dry mouth, clinically known as xerostomia, has surged in prevalence as a side effect of cancer therapies, medication regimens, and the natural aging process. This dynamic has propelled research and development efforts toward increasingly sophisticated saliva substitutes designed to replicate not only lubrication but also the protective enzymatic and antimicrobial properties of natural saliva.

The market’s maturation is underscored by the emergence of novel formulations that extend beyond traditional watery drops to encompass gels that adhere to oral mucosa, mouthwashes that offer sustained relief, and sprays engineered for rapid delivery. As regulatory frameworks adapt to these innovations, manufacturers and healthcare providers alike are collaborating more closely than ever to ensure safety, efficacy, and patient-centric design. This introduction lays the groundwork for a deeper exploration into the forces reshaping the artificial saliva landscape, from tariff implications to segmentation nuances, and sets the stage for actionable recommendations that decision-makers can leverage to achieve competitive advantage.

The Evolutionary Forces Redefining the Market Landscape

Recent years have witnessed a series of pivotal inflection points reshaping the artificial saliva market. Advances in biomimetic materials have unlocked the ability to engineer synthetic formulations that closely mirror the viscoelasticity and biochemical profile of natural secretions. Concurrently, breakthroughs in drug delivery technologies have enabled combination products that integrate therapeutic agents to address underlying pathologies while alleviating discomfort.

Regulatory bodies across major economies have also accelerated review processes for medical device classifications, fostering an environment where innovation can flourish under robust safety protocols. At the same time, the patient voice has become an influential force, as digital health platforms amplify real-world experiences and preferences. These transformative shifts have driven a more collaborative ecosystem in which academic institutions, contract manufacturers, and oral care firms coalesce to fast-track product development. The result is a landscape defined by heightened competition, multifunctional product portfolios, and a relentless focus on enhancing patient quality of life.

Navigating the Effects of US Tariffs in 2025

In 2025, the imposition of new tariffs on raw materials and finished medical device imports into the United States has reverberated across the artificial saliva industry. Suppliers reliant on high-purity polymers and specialized enzymes have encountered sharp cost increases, necessitating strategic realignments in procurement and production. Some manufacturers have mitigated these pressures by forging alternative sourcing partnerships in Asia-Pacific, where integrated supply chains offer competitive pricing and logistical resilience.

Meanwhile, domestic producers have leveraged the tariff environment as an opportunity to expand local manufacturing capacity, securing government incentives aimed at bolstering health care self-sufficiency. The net effect has been a recalibration of price structures, prompting end users such as hospitals and retail pharmacies to reassess product portfolios and adjust stocking strategies. As a consequence, market entrants are prioritizing formulations with optimized raw material profiles that maintain therapeutic performance while reducing exposure to tariff volatility.

Unveiling Critical Segmentation Dynamics

The product type spectrum-encompassing droplets, viscous gels, refreshing mouthwashes, and precision sprays-reveals distinctive adoption patterns driven by patient demographics and clinical settings. While droplets remain a foundational offering for at-home management, gels have gained traction in institutional contexts where longer retention on oral tissues is paramount. Spray formulations, prized for their ease of use in outpatient environments, have emerged as a bridge between acute relief and convenience.

Formulation choices divide broadly into natural and synthetic variants, each presenting trade-offs in cost, shelf life, and biochemical fidelity. Natural derivatives benefit from patient perception of organic origin, yet synthetic analogues allow for tighter control over viscosity and antimicrobial function. End user segmentation highlights the dual pathways of healthcare institutions and home care consumers, with dental offices increasingly integrating artificial saliva into comprehensive oral health regimens, and nursing homes embracing user-friendly packaging to support resident compliance.

Distribution channels split between offline networks-including hospital pharmacies, retail outlets, and specialty stores-and burgeoning online platforms that capitalize on telehealth linkages and subscription models. Indications such as medication-induced dry mouth, radiation-induced xerostomia, and Sjogren’s syndrome define patient cohorts with distinct therapeutic demands, while packaging formats ranging from multi-dose dispensers to travel-ready single-use packs cater to diverse usage scenarios.

Dissecting Regional Market Nuances

The Americas region continues to lead in revenue generation, propelled by robust reimbursement frameworks and a well-established network of healthcare providers who integrate artificial saliva into chronic care protocols. Innovation hubs in North America are driving product diversification, while Latin American markets are showing rising uptake as awareness campaigns and public health initiatives spotlight xerostomia management.

In Europe, Middle East & Africa, regulatory harmonization under the European Medical Device Regulation has heightened product standards, fostering closer collaboration between manufacturers and notified bodies. The Middle East is leveraging public-private partnerships to upgrade oncology and geriatric care facilities, thereby stimulating demand. Africa presents pockets of opportunity where pilot programs in tertiary hospitals are validating the clinical and economic benefits of saliva substitutes.

Asia-Pacific stands out for its manufacturing prowess and cost-efficient raw material sourcing, underpinning a growing export footprint. Domestic consumption in key markets like China and Japan is accelerating as aging populations drive higher prevalence of dry mouth conditions. Governments across the region are prioritizing healthcare infrastructure investments, further expanding distribution channels through e-pharmacies and telemedicine.

Spotlight on Leading Innovators and Market Contenders

A cadre of established pharmaceutical companies and specialized oral care firms anchors the competitive landscape. Industry leaders are channeling significant R&D investments into next-generation biomimetic polymers and microencapsulation technologies that prolong active agent release. Collaborative ventures between device manufacturers and biotech startups are producing hybrid solutions that combine lubrication with targeted antimicrobial delivery.

Mergers and acquisitions have been a key mechanism for portfolio expansion, enabling larger players to integrate innovative product lines while scaling manufacturing efficiency. Strategic alliances with distributors ensure that both hospital systems and retail networks benefit from cohesive educational support programs aimed at healthcare professionals. Simultaneously, emerging challengers are differentiating through digital engagement platforms that allow prescribers to track patient adherence and outcomes in real time.

The competitive dynamic underscores the importance of agility, with companies that can swiftly align product design to clinical feedback and regulatory updates gaining market share. Proprietary formulations guarded by strong intellectual property portfolios are emerging as critical assets in an environment where performance and safety claims are rigorously scrutinized.

Strategic Imperatives for Future Success

Industry leaders should prioritize the integration of data-driven insights into product development lifecycles, harnessing real-world evidence to refine efficacy profiles and patient satisfaction metrics. Establishing strategic procurement alliances in low-tariff jurisdictions can safeguard margins and ensure continuity of supply, while dual-sourcing strategies mitigate geopolitical risk. Organizations poised for growth will also strengthen partnerships with dental networks and long-term care facilities, embedding saliva substitutes into standard care pathways through education and training initiatives.

Investing in digital platforms that facilitate remote monitoring and subscription-based dispensing will meet rising consumer expectations for convenience and personalized care. On the regulatory front, engaging proactively with health authorities to shape standards for novel biomaterials can accelerate time to market and confer first-mover advantages. Finally, companies must cultivate agile manufacturing frameworks capable of rapid product reformulation and packaging optimization in response to evolving patient preferences and clinical guidelines.

Rigorous Methodology Underpinning the Analysis

This analysis synthesizes findings from extensive secondary research in peer-reviewed journals, regulatory filings, and industry publications. Primary insights were gathered through in-depth interviews with key opinion leaders across dental, oncology, and geriatric specialties, supplemented by surveys of procurement professionals in hospital and retail settings. Data triangulation methods ensured that quantitative metrics aligned with qualitative perspectives on market dynamics.

Market segmentation was validated through a combination of sales data analysis and field-level feedback, ensuring that product type, formulation, end-user, distribution channel, indication, and packaging frameworks accurately reflect real-world usage. Regional insights were corroborated with on-the-ground intelligence from regional distributors and healthcare associations. A rigorous review process by internal experts and external advisors guaranteed methodological robustness and impartiality, while continuous updates incorporated the latest developments in tariffs, regulatory changes, and clinical research.

Synthesizing Insights for Decisive Action

The artificial saliva market stands poised at a strategic inflection point where technological breakthroughs, evolving regulatory norms, and shifting patient expectations converge to create new avenues for growth. Stakeholders who leverage the insights outlined in this report will be well-positioned to anticipate demand patterns, optimize product portfolios, and navigate cost pressures driven by tariff dynamics. By aligning R&D, manufacturing, and commercial strategies with the critical segmentation and regional nuances detailed herein, organizations can achieve sustained competitive advantage and deliver superior patient outcomes.

As the landscape continues to evolve, ongoing vigilance will be essential to capitalize on emerging opportunities in novel formulations, digital health integration, and strategic partnerships. This conclusion underscores the imperative for cohesive, forward-looking planning that balances innovation with operational resilience in a market defined by both complexity and promise.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Product Type
    • Drops
    • Gel
    • Mouthwash
    • Spray
  • Formulation
    • Natural
    • Synthetic
  • End User
    • Healthcare Institutions
      • Dental Offices
      • Hospitals/Clinics
      • Nursing Homes
    • Home Care
  • Distribution Channel
    • Offline
      • Hospital Pharmacies
      • Retail Pharmacies
      • Specialty Stores
    • Online
  • Indication
    • Medication-Induced Dry Mouth
    • Radiation-Induced Xerostomia
    • Sjogren’s Syndrome
  • Packaging
    • Multi Dose
    • Single Dose
    • Travel Pack
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report categorizes to delves into recent significant developments and analyze trends in each of the following companies:
  • GlaxoSmithKline plc
  • I-Med Pharma Inc.
  • Colgate-Palmolive Company
  • Sunstar Suisse SA
  • Novartis AG
  • Johnson & Johnson Services, Inc.
  • GC Corporation
  • Cipla Limited
  • 3M Company
  • Dentsply Sirona Inc.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Artificial Saliva Market, by Product Type
8.1. Introduction
8.2. Drops
8.3. Gel
8.4. Mouthwash
8.5. Spray
9. Artificial Saliva Market, by Formulation
9.1. Introduction
9.2. Natural
9.3. Synthetic
10. Artificial Saliva Market, by End User
10.1. Introduction
10.2. Healthcare Institutions
10.2.1. Dental Offices
10.2.2. Hospitals/Clinics
10.2.3. Nursing Homes
10.3. Home Care
11. Artificial Saliva Market, by Distribution Channel
11.1. Introduction
11.2. Offline
11.2.1. Hospital Pharmacies
11.2.2. Retail Pharmacies
11.2.3. Specialty Stores
11.3. Online
12. Artificial Saliva Market, by Indication
12.1. Introduction
12.2. Medication-Induced Dry Mouth
12.3. Radiation-Induced Xerostomia
12.4. Sjogren’s Syndrome
13. Artificial Saliva Market, by Packaging
13.1. Introduction
13.2. Multi Dose
13.3. Single Dose
13.4. Travel Pack
14. Americas Artificial Saliva Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Artificial Saliva Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Artificial Saliva Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. GlaxoSmithKline plc
17.3.2. I-Med Pharma Inc.
17.3.3. Colgate-Palmolive Company
17.3.4. Sunstar Suisse SA
17.3.5. Novartis AG
17.3.6. Johnson & Johnson Services, Inc.
17.3.7. GC Corporation
17.3.8. Cipla Limited
17.3.9. 3M Company
17.3.10. Dentsply Sirona Inc.
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. ARTIFICIAL SALIVA MARKET MULTI-CURRENCY
FIGURE 2. ARTIFICIAL SALIVA MARKET MULTI-LANGUAGE
FIGURE 3. ARTIFICIAL SALIVA MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL ARTIFICIAL SALIVA MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL ARTIFICIAL SALIVA MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL ARTIFICIAL SALIVA MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL ARTIFICIAL SALIVA MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL ARTIFICIAL SALIVA MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL ARTIFICIAL SALIVA MARKET SIZE, BY FORMULATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL ARTIFICIAL SALIVA MARKET SIZE, BY FORMULATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL ARTIFICIAL SALIVA MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL ARTIFICIAL SALIVA MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL ARTIFICIAL SALIVA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 14. GLOBAL ARTIFICIAL SALIVA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL ARTIFICIAL SALIVA MARKET SIZE, BY INDICATION, 2024 VS 2030 (%)
FIGURE 16. GLOBAL ARTIFICIAL SALIVA MARKET SIZE, BY INDICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL ARTIFICIAL SALIVA MARKET SIZE, BY PACKAGING, 2024 VS 2030 (%)
FIGURE 18. GLOBAL ARTIFICIAL SALIVA MARKET SIZE, BY PACKAGING, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. AMERICAS ARTIFICIAL SALIVA MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. AMERICAS ARTIFICIAL SALIVA MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. UNITED STATES ARTIFICIAL SALIVA MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 22. UNITED STATES ARTIFICIAL SALIVA MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL SALIVA MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL SALIVA MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ASIA-PACIFIC ARTIFICIAL SALIVA MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. ASIA-PACIFIC ARTIFICIAL SALIVA MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. ARTIFICIAL SALIVA MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 28. ARTIFICIAL SALIVA MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. ARTIFICIAL SALIVA MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL ARTIFICIAL SALIVA MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL ARTIFICIAL SALIVA MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL ARTIFICIAL SALIVA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL ARTIFICIAL SALIVA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL ARTIFICIAL SALIVA MARKET SIZE, BY DROPS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL ARTIFICIAL SALIVA MARKET SIZE, BY GEL, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL ARTIFICIAL SALIVA MARKET SIZE, BY MOUTHWASH, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL ARTIFICIAL SALIVA MARKET SIZE, BY SPRAY, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL ARTIFICIAL SALIVA MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL ARTIFICIAL SALIVA MARKET SIZE, BY NATURAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL ARTIFICIAL SALIVA MARKET SIZE, BY SYNTHETIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL ARTIFICIAL SALIVA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL ARTIFICIAL SALIVA MARKET SIZE, BY HEALTHCARE INSTITUTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL ARTIFICIAL SALIVA MARKET SIZE, BY DENTAL OFFICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL ARTIFICIAL SALIVA MARKET SIZE, BY HOSPITALS/CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL ARTIFICIAL SALIVA MARKET SIZE, BY NURSING HOMES, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL ARTIFICIAL SALIVA MARKET SIZE, BY HEALTHCARE INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL ARTIFICIAL SALIVA MARKET SIZE, BY HOME CARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL ARTIFICIAL SALIVA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL ARTIFICIAL SALIVA MARKET SIZE, BY OFFLINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL ARTIFICIAL SALIVA MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL ARTIFICIAL SALIVA MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL ARTIFICIAL SALIVA MARKET SIZE, BY SPECIALTY STORES, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL ARTIFICIAL SALIVA MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL ARTIFICIAL SALIVA MARKET SIZE, BY ONLINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL ARTIFICIAL SALIVA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL ARTIFICIAL SALIVA MARKET SIZE, BY MEDICATION-INDUCED DRY MOUTH, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL ARTIFICIAL SALIVA MARKET SIZE, BY RADIATION-INDUCED XEROSTOMIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL ARTIFICIAL SALIVA MARKET SIZE, BY SJOGREN’S SYNDROME, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL ARTIFICIAL SALIVA MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL ARTIFICIAL SALIVA MARKET SIZE, BY MULTI DOSE, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL ARTIFICIAL SALIVA MARKET SIZE, BY SINGLE DOSE, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL ARTIFICIAL SALIVA MARKET SIZE, BY TRAVEL PACK, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. AMERICAS ARTIFICIAL SALIVA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 37. AMERICAS ARTIFICIAL SALIVA MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 38. AMERICAS ARTIFICIAL SALIVA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 39. AMERICAS ARTIFICIAL SALIVA MARKET SIZE, BY HEALTHCARE INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 40. AMERICAS ARTIFICIAL SALIVA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 41. AMERICAS ARTIFICIAL SALIVA MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 42. AMERICAS ARTIFICIAL SALIVA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 43. AMERICAS ARTIFICIAL SALIVA MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
TABLE 44. AMERICAS ARTIFICIAL SALIVA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 45. UNITED STATES ARTIFICIAL SALIVA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 46. UNITED STATES ARTIFICIAL SALIVA MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 47. UNITED STATES ARTIFICIAL SALIVA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 48. UNITED STATES ARTIFICIAL SALIVA MARKET SIZE, BY HEALTHCARE INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 49. UNITED STATES ARTIFICIAL SALIVA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 50. UNITED STATES ARTIFICIAL SALIVA MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 51. UNITED STATES ARTIFICIAL SALIVA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 52. UNITED STATES ARTIFICIAL SALIVA MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
TABLE 53. UNITED STATES ARTIFICIAL SALIVA MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 54. CANADA ARTIFICIAL SALIVA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 55. CANADA ARTIFICIAL SALIVA MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 56. CANADA ARTIFICIAL SALIVA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 57. CANADA ARTIFICIAL SALIVA MARKET SIZE, BY HEALTHCARE INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 58. CANADA ARTIFICIAL SALIVA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 59. CANADA ARTIFICIAL SALIVA MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 60. CANADA ARTIFICIAL SALIVA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 61. CANADA ARTIFICIAL SALIVA MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
TABLE 62. MEXICO ARTIFICIAL SALIVA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 63. MEXICO ARTIFICIAL SALIVA MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 64. MEXICO ARTIFICIAL SALIVA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 65. MEXICO ARTIFICIAL SALIVA MARKET SIZE, BY HEALTHCARE INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 66. MEXICO ARTIFICIAL SALIVA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 67. MEXICO ARTIFICIAL SALIVA MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 68. MEXICO ARTIFICIAL SALIVA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 69. MEXICO ARTIFICIAL SALIVA MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
TABLE 70. BRAZIL ARTIFICIAL SALIVA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 71. BRAZIL ARTIFICIAL SALIVA MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 72. BRAZIL ARTIFICIAL SALIVA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 73. BRAZIL ARTIFICIAL SALIVA MARKET SIZE, BY HEALTHCARE INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 74. BRAZIL ARTIFICIAL SALIVA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 75. BRAZIL ARTIFICIAL SALIVA MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 76. BRAZIL ARTIFICIAL SALIVA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 77. BRAZIL ARTIFICIAL SALIVA MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
TABLE 78. ARGENTINA ARTIFICIAL SALIVA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 79. ARGENTINA ARTIFICIAL SALIVA MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 80. ARGENTINA ARTIFICIAL SALIVA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 81. ARGENTINA ARTIFICIAL SALIVA MARKET SIZE, BY HEALTHCARE INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 82. ARGENTINA ARTIFICIAL SALIVA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 83. ARGENTINA ARTIFICIAL SALIVA MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 84. ARGENTINA ARTIFICIAL SALIVA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 85. ARGENTINA ARTIFICIAL SALIVA MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
TABLE 86. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL SALIVA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 87. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL SALIVA MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 88. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL SALIVA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 89. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL SALIVA MARKET SIZE, BY HEALTHCARE INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 90. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL SALIVA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 91. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL SALIVA MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 92. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL SALIVA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 93. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL SALIVA MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
TABLE 94. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL SALIVA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 95. UNITED KINGDOM ARTIFICIAL SALIVA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 96. UNITED KINGDOM ARTIFICIAL SALIVA MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 97. UNITED KINGDOM ARTIFICIAL SALIVA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 98. UNITED KINGDOM ARTIFICIAL SALIVA MARKET SIZE, BY HEALTHCARE INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 99. UNITED KINGDOM ARTIFICIAL SALIVA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 100. UNITED KINGDOM ARTIFICIAL SALIVA MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 101. UNITED KINGDOM ARTIFICIAL SALIVA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 102. UNITED KINGDOM ARTIFICIAL SALIVA MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
TABLE 103. GERMANY ARTIFICIAL SALIVA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 104. GERMANY ARTIFICIAL SALIVA MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 105. GERMANY ARTIFICIAL SALIVA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 106. GERMANY ARTIFICIAL SALIVA MARKET SIZE, BY HEALTHCARE INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 107. GERMANY ARTIFICIAL SALIVA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 108. GERMANY ARTIFICIAL SALIVA MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 109. GERMANY ARTIFICIAL SALIVA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 110. GERMANY ARTIFICIAL SALIVA MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
TABLE 111. FRANCE ARTIFICIAL SALIVA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 112. FRANCE ARTIFICIAL SALIVA MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 113. FRANCE ARTIFICIAL SALIVA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 114. FRANCE ARTIFICIAL SALIVA MARKET SIZE, BY HEALTHCARE INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 115. FRANCE ARTIFICIAL SALIVA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 116. FRANCE ARTIFICIAL SALIVA MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 117. FRANCE ARTIFICIAL SALIVA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 118. FRANCE ARTIFICIAL SALIVA MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
TABLE 119. RUSSIA ARTIFICIAL SALIVA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 120. RUSSIA ARTIFICIAL SALIVA MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 121. RUSSIA ARTIFICIAL SALIVA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 122. RUSSIA ARTIFICIAL SALIVA MARKET SIZE, BY HEALTHCARE INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 123. RUSSIA ARTIFICIAL SALIVA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 124. RUSSIA ARTIFICIAL SALIVA MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 125. RUSSIA ARTIFICIAL SALIVA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 126. RUSSIA ARTIFICIAL SALIVA MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
TABLE 127. ITALY ARTIFICIAL SALIVA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 128. ITALY ARTIFICIAL SALIVA MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 129. ITALY ARTIFICIAL SALIVA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 130. ITALY ARTIFICIAL SALIVA MARKET SIZE, BY HEALTHCARE INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 131. ITALY ARTIFICIAL SALIVA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 132. ITALY ARTIFICIAL SALIVA MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 133. ITALY ARTIFICIAL SALIVA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 134. ITALY ARTIFICIAL SALIVA MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
TABLE 135. SPAIN ARTIFICIAL SALIVA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 136. SPAIN ARTIFICIAL SALIVA MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 137. SPAIN ARTIFICIAL SALIVA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 138. SPAIN ARTIFICIAL SALIVA MARKET SIZE, BY HEALTHCARE INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 139. SPAIN ARTIFICIAL SALIVA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 140. SPAIN ARTIFICIAL SALIVA MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 141. SPAIN ARTIFICIAL SALIVA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 142. SPAIN ARTIFICIAL SALIVA MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
TABLE 143. UNITED ARAB EMIRATES ARTIFICIAL SALIVA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 144. UNITED ARAB EMIRATES ARTIFICIAL SALIVA MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 145. UNITED ARAB EMIRATES ARTIFICIAL SALIVA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 146. UNITED ARAB EMIRATES ARTIFICIAL SALIVA MARKET SIZE, BY HEALTHCARE INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 147. UNITED ARAB EMIRATES ARTIFICIAL SALIVA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 148. UNITED ARAB EMIRATES ARTIFICIAL SALIVA MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 149. UNITED ARAB EMIRATES ARTIFICIAL SALIVA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 150. UNITED ARAB EMIRATES ARTIFICIAL SALIVA MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
TABLE 151. SAUDI ARABIA ARTIFICIAL SALIVA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 152. SAUDI ARABIA ARTIFICIAL SALIVA MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 153. SAUDI ARABIA ARTIFICIAL SALIVA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 154. SAUDI ARABIA ARTIFICIAL SALIVA MARKET SIZE, BY HEALTHCARE INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 155. SAUDI ARABIA ARTIFICIAL SALIVA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 156. SAUDI ARABIA ARTIFICIAL SALIVA MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 157. SAUDI ARABIA ARTIFICIAL SALIVA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 158. SAUDI ARABIA ARTIFICIAL SALIVA MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
TABLE 159. SOUTH AFRICA ARTIFICIAL SALIVA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 160. SOUTH AFRICA ARTIFICIAL SALIVA MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 161. SOUTH AFRICA ARTIFICIAL SALIVA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 162. SOUTH AFRICA ARTIFICIAL SALIVA MARKET SIZE, BY HEALTHCARE INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 163. SOUTH AFRICA ARTIFICIAL SALIVA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 164. SOUTH AFRICA ARTIFICIAL SALIVA MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 165. SOUTH AFRICA ARTIFICIAL SALIVA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 166. SOUTH AFRICA ARTIFICIAL SALIVA MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
TABLE 167. DENMARK ARTIFICIAL SALIVA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 168. DENMARK ARTIFICIAL SALIVA MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 169. DENMARK ARTIFICIAL SALIVA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 170. DENMARK ARTIFICIAL SALIVA MARKET SIZE, BY HEALTHCARE INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 171. DENMARK ARTIFICIAL SALIVA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 172. DENMARK ARTIFICIAL SALIVA MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 173. DENMARK ARTIFICIAL SALIVA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 174. DENMARK ARTIFICIAL SALIVA MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
TABLE 175. NETHERLANDS ARTIFICIAL SALIVA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 176. NETHERLANDS ARTIFICIAL SALIVA MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 177. NETHERLANDS ARTIFICIAL SALIVA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 178. NETHERLANDS ARTIFICIAL SALIVA MARKET SIZE, BY HEALTHCARE INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 179. NETHERLANDS ARTIFICIAL SALIVA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 180. NETHERLANDS ARTIFICIAL SALIVA MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 181. NETHERLANDS ARTIFICIAL SALIVA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 182. NETHERLANDS ARTIFICIAL SALIVA MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
TABLE 183. QATAR ARTIFICIAL SALIVA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 184. QATAR ARTIFICIAL SALIVA MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 185. QATAR ARTIFICIAL SALIVA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 186. QATAR ARTIFICIAL SALIVA MARKET SIZE, BY HEALTHCARE INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 187. QATAR ARTIFICIAL SALIVA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 188. QATAR ARTIFICIAL SALIVA MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 189. QATAR ARTIFICIAL SALIVA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 190. QATAR ARTIFICIAL SALIVA MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
TABLE 191. FINLAND ARTIFICIAL SALIVA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 192. FINLAND ARTIFICIAL SALIVA MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 193. FINLAND ARTIFICIAL SALIVA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 194. FINLAND ARTIFICIAL SALIVA MARKET SIZE, BY HEALTHCARE INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 195. FINLAND ARTIFICIAL SALIVA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 196. FINLAND ARTIFICIAL SALIVA MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 197. FINLAND ARTIFICIAL SALIVA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 198. FINLAND ARTIFICIAL SALIVA MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
TABLE 199. SWEDEN ARTIFICIAL SALIVA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 200. SWEDEN ARTIFICIAL SALIVA MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 201. SWEDEN ARTIFICIAL SALIVA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 202. SWEDEN ARTIFICIAL SALIVA MARKET SIZE, BY HEALTHCARE INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 203. SWEDEN ARTIFICIAL SALIVA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 204. SWEDEN ARTIFICIAL SALIVA MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 205. SWEDEN ARTIFICIAL SALIVA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 206. SWEDEN ARTIFICIAL SALIVA MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
TABLE 207. NIGERIA ARTIFICIAL SALIVA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 208. NIGERIA ARTIFICIAL SALIVA MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 209. NIGERIA ARTIFICIAL SALIVA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 210. NIGERIA ARTIFICIAL SALIVA MARKET SIZE, BY HEALTHCARE INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 211. NIGERIA ARTIFICIAL SALIVA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 212. NIGERIA ARTIFICIAL SALIVA MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 213. NIGERIA ARTIFICIAL SALIVA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 214. NIGERIA ARTIFICIAL SALIVA MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
TABLE 215. EGYPT ARTIFICIAL SALIVA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 216. EGYPT ARTIFICIAL SALIVA MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 217. EGYPT ARTIFICIAL SALIVA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 218. EGYPT ARTIFICIAL SALIVA MARKET SIZE, BY HEALTHCARE INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 219. EGYPT ARTIFICIAL SALIVA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 220. EGYPT ARTIFICIAL SALIVA MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 221. EGYPT ARTIFICIAL SALIVA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 222. EGYPT ARTIFICIAL SALIVA MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
TABLE 223. TURKEY ARTIFICIAL SALIVA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 224. TURKEY ARTIFICIAL SALIVA MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 225. TURKEY ARTIFICIAL SALIVA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 226. TURKEY ARTIFICIAL SALIVA MARKET SIZE, BY HEALTHCARE INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 227. TURKEY ARTIFICIAL SALIVA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 228. TURKEY ARTIFICIAL SALIVA MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 229. TURKEY ARTIFICIAL SALIVA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 230. TURKEY ARTIFICIAL SALIVA MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
TABLE 231. ISRAEL ARTIFICIAL SALIVA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 232. ISRAEL ARTIFICIAL SALIVA MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 233. ISRAEL ARTIFICIAL SALIVA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 234. ISRAEL ARTIFICIAL SALIVA MARKET SIZE, BY HEALTHCARE INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 235. ISRAEL ARTIFICIAL SALIVA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 236. ISRAEL ARTIFICIAL SALIVA MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 237. ISRAEL ARTIFICIAL SALIVA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 238. ISRAEL ARTIFICIAL SALIVA MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
TABLE 239. NORWAY ARTIFICIAL SALIVA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 240. NORWAY ARTIFICIAL SALIVA MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 241. NORWAY ARTIFICIAL SALIVA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 242. NORWAY ARTIFICIAL SALIVA MARKET SIZE, BY HEALTHCARE INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 243. NORWAY ARTIFICIAL SALIVA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 244. NORWAY ARTIFICIAL SALIVA MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 245. NORWAY ARTIFICIAL SALIVA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 246. NORWAY ARTIFICIAL SALIVA MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
TABLE 247. POLAND ARTIFICIAL SALIVA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 248. POLAND ARTIFICIAL SALIVA MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 249. POLAND ARTIFICIAL SALIVA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 250. POLAND ARTIFICIAL SALIVA MARKET SIZE, BY HEALTHCARE INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 251. POLAND ARTIFICIAL SALIVA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 252. POLAND ARTIFICIAL SALIVA MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 253. POLAND ARTIFICIAL SALIVA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 254. POLAND ARTIFICIAL SALIVA MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
TABLE 255. SWITZERLAND ARTIFICIAL SALIVA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 256. SWITZERLAND ARTIFICIAL SALIVA MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 257. SWITZERLAND ARTIFICIAL SALIVA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 258. SWITZERLAND ARTIFICIAL SALIVA MARKET SIZE, BY HEALTHCARE INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 259. SWITZERLAND ARTIFICIAL SALIVA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 260. SWITZERLAND ARTIFICIAL SALIVA MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 261. SWITZERLAND ARTIFICIAL SALIVA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 262. SWITZERLAND ARTIFICIAL SALIVA MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
TABLE 263. ASIA-PACIFIC ARTIFICIAL SALIVA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 264. ASIA-PACIFIC ARTIFICIAL SALIVA MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 265. ASIA-PACIFIC ARTIFICIAL SALIVA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 266. ASIA-PACIFIC ARTIFICIAL SALIVA MARKET SIZE, BY HEALTHCARE INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 267. ASIA-PACIFIC ARTIFICIAL SALIVA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 268. ASIA-PACIFIC ARTIFICIAL SALIVA MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 269. ASIA-PACIFIC ARTIFICIAL SALIVA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 270. ASIA-PACIFIC ARTIFICIAL SALIVA MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
TABLE 271. ASIA-PACIFIC ARTIFICIAL SALIVA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 272. CHINA ARTIFICIAL SALIVA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 273. CHINA ARTIFICIAL SALIVA MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 274. CHINA ARTIFICIAL SALIVA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 275. CHINA ARTIFICIAL SALIVA MARKET SIZE, BY HEALTHCARE INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 276. CHINA ARTIFICIAL SALIVA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 277. CHINA ARTIFICIAL SALIVA MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 278. CHINA ARTIFICIAL SALIVA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 279. CHINA ARTIFICIAL SALIVA MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
TABLE 280. INDIA ARTIFICIAL SALIVA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 281. INDIA ARTIFICIAL SALIVA MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 282. INDIA ARTIFICIAL SALIVA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 283. INDIA ARTIFICIAL SALIVA MARKET SIZE, BY HEALTHCARE INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 284. INDIA ARTIFICIAL SALIVA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 285. INDIA ARTIFICIAL SALIVA MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 286. INDIA ARTIFICIAL SALIVA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 287. INDIA ARTIFICIAL SALIVA MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
TABLE 288. JAPAN ARTIFICIAL SALIVA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 289. JAPAN ARTIFICIAL SALIVA MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 290. JAPAN ARTIFICIAL SALIVA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 291. JAPAN ARTIFICIAL SALIVA MARKET SIZE, BY HEALTHCARE INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 292. JAPAN ARTIFICIAL SALIVA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 293. JAPAN ARTIFICIAL SALIVA MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 294. JAPAN ARTIFICIAL SALIVA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 295. JAPAN ARTIFICIAL SALIVA MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
TABLE 296. AUSTRALIA ARTIFICIAL SALIVA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 297. AUSTRALIA ARTIFICIAL SALIVA MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 298. AUSTRALIA ARTIFICIAL SALIVA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 299. AUSTRALIA ARTIFICIAL SALIVA MARKET SIZE, BY HEALTHCARE INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 300. AUSTRALIA ARTIFICIAL SALIVA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 301. AUSTRALIA ARTIFICIAL SALIVA MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 302. AUSTRALIA ARTIFICIAL SALIVA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 303. AUSTRALIA ARTIFICIAL SALIVA MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
TABLE 304. SOUTH KOREA ARTIFICIAL SALIVA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 305. SOUTH KOREA ARTIFICIAL SALIVA MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 306. SOUTH KOREA ARTIFICIAL SALIVA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 307. SOUTH KOREA ARTIFICIAL SALIVA MARKET SIZE, BY HEALTHCARE INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 308. SOUTH KOREA ARTIFICIAL SALIVA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 309. SOUTH KOREA ARTIFICIAL SALIVA MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 310. SOUTH KOREA ARTIFICIAL SALIVA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 311. SOUTH KOREA ARTIFICIAL SALIVA MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
TABLE 312. INDONESIA ARTIFICIAL SALIVA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 313. INDONESIA ARTIFICIAL SALIVA MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 314. INDONESIA ARTIFICIAL SALIVA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 315. INDONESIA ARTIFICIAL SALIVA MARKET SIZE, BY HEALTHCARE INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 316. INDONESIA ARTIFICIAL SALIVA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 317. INDONESIA ARTIFICIAL SALIVA MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 318. INDONESIA ARTIFICIAL SALIVA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 319. INDONESIA ARTIFICIAL SALIVA MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
TABLE 320. THAILAND ARTIFICIAL SALIVA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 321. THAILAND ARTIFICIAL SALIVA MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 322. THAILAND ARTIFICIAL SALIVA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 323. THAILAND ARTIFICIAL SALIVA MARKET SIZE, BY HEALTHCARE INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 324. THAILAND ARTIFICIAL SALIVA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 325. THAILAND ARTIFICIAL SALIVA MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 326. THAILAND ARTIFICIAL SALIVA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 327. THAILAND ARTIFICIAL SALIVA MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
TABLE 328. PHILIPPINES ARTIFICIAL SALIVA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 329. PHILIPPINES ARTIFICIAL SALIVA MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 330. PHILIPPINES ARTIFICIAL SALIVA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 331. PHILIPPINES ARTIFICIAL SALIVA MARKET SIZE, BY HEALTHCARE INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 332. PHILIPPINES ARTIFICIAL SALIVA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 333. PHILIPPINES ARTIFICIAL SALIVA MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 334. PHILIPPINES ARTIFICIAL SALIVA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 335. PHILIPPINES ARTIFICIAL SALIVA MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
TABLE 336. MALAYSIA ARTIFICIAL SALIVA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 337. MALAYSIA ARTIFICIAL SALIVA MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 338. MALAYSIA ARTIFICIAL SALIVA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 339. MALAYSIA ARTIFICIAL SALIVA MARKET SIZE, BY HEALTHCARE INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 340. MALAYSIA ARTIFICIAL SALIVA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 341. MALAYSIA ARTIFICIAL SALIVA MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 342. MALAYSIA ARTIFICIAL SALIVA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 343. MALAYSIA ARTIFICIAL SALIVA MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
TABLE 344. SINGAPORE ARTIFICIAL SALIVA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 345. SINGAPORE ARTIFICIAL SALIVA MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 346. SINGAPORE ARTIFICIAL SALIVA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 347. SINGAPORE ARTIFICIAL SALIVA MARKET SIZE, BY HEALTHCARE INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 348. SINGAPORE ARTIFICIAL SALIVA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 349. SINGAPORE ARTIFICIAL SALIVA MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 350. SINGAPORE ARTIFICIAL SALIVA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 351. SINGAPORE ARTIFICIAL SALIVA MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
TABLE 352. VIETNAM ARTIFICIAL SALIVA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 353. VI

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Artificial Saliva market report include:
  • GlaxoSmithKline plc
  • I-Med Pharma Inc.
  • Colgate-Palmolive Company
  • Sunstar Suisse SA
  • Novartis AG
  • Johnson & Johnson Services, Inc.
  • GC Corporation
  • Cipla Limited
  • 3M Company
  • Dentsply Sirona Inc.

Table Information

Report AttributeDetails
No. of Pages180
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 1.04 Billion
Forecasted Market Value ( USD ) by 2030 $ 1.42 Billion
Compound Annual Growth Rate6.3%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Artificial Saliva - Global Strategic Business Report - Product Image

Artificial Saliva - Global Strategic Business Report

  • Report
  • 182 Pages
  • Global
From
Artificial Saliva Market Report and Forecast 2024-2032 - Product Image

Artificial Saliva Market Report and Forecast 2024-2032

  • Report
  • 200 Pages
  • Global
From
Artificial Saliva Market Report 2025 - Product Image

Artificial Saliva Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Gastroesophageal Reflux Disease (GERD) Treatment Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Image

Gastroesophageal Reflux Disease (GERD) Treatment Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Report
  • 100 Pages
  • Global
From
Sulfmethoxazole,Trimethoprim,Boneol & Artificial Cow-bezoar Tablets Market by Distribution Channel, End User, Product Type, Dosage Strength, Packaging Type - Global Forecast to 2030 - Product Image

Sulfmethoxazole,Trimethoprim,Boneol & Artificial Cow-bezoar Tablets Market by Distribution Channel, End User, Product Type, Dosage Strength, Packaging Type - Global Forecast to 2030

  • Report
  • 195 Pages
  • Global
From

About the Artificial Saliva Market

The Artificial Saliva market is a subset of the Immune Disorders Drugs market, focusing on the development of treatments for dry mouth and other related conditions. Artificial saliva is a synthetic substance designed to mimic the properties of natural saliva, and is used to treat dry mouth, a condition caused by a lack of saliva production. Artificial saliva is also used to treat other conditions such as xerostomia, dysphagia, and oral mucositis. It is available in various forms, including sprays, gels, and lozenges. The Artificial Saliva market is driven by the increasing prevalence of dry mouth and other related conditions, as well as the growing demand for effective treatments. Additionally, the development of new technologies and the increasing availability of artificial saliva products are expected to drive the market growth. Some companies in the Artificial Saliva market include Biotène, Oasis, and Salivart. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.